Schedule 13G ownership disclosure

Forte Biosciences Inc

Common Stock · CUSIP: 34962G208

Event date: 2025-12-31

Filing-level shares
1,425,785
Percent of class
11.4%
  • JANUS HENDERSON GROUP PLC

    Shares: 1,425,785 · Class: 11.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-26-000094
Form type
SCHEDULE 13G/A
Filer
Forte Biosciences, Inc.
CIK
CIK 1419041
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G/A | SEC Filings Hub